5:14 PM
Sep 28, 2011
 |  BC Extra  |  Clinical News

NIH stops Viread arm in HIV prevention trial

NIH said it discontinued the oral Viread tenofovir arm in the Phase IIb VOICE (MTN-003) trial to prevent HIV after an interim futility analysis showed Viread would not...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >